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ess: runa.hallin@medscSummary Loss of body weight, as a result of imbalance between increased energy
demand and/or reduced dietary intake, is a common problem in patients with COPD.
The aim of this investigation was to examine the relationship between nutritional
intake, change in body weight and the risk of exacerbation in patients with COPD.
The study comprised 41 patients who were hospitalised because of an
exacerbation of COPD. The follow-up period was 12 months. Weight, height and
lung function were measured at baseline. At the 12-month follow-up, weight change
and current weight were assessed by an interview and nutritional intake was
recorded in a food diary for 7 days. An acute exacerbation was defined as having
been admitted to hospital and/or making an emergency visit to hospital, due to
COPD during the follow-up period.
At baseline, 24% of the patients were underweight (body mass index (BMI)o20 kg/
m2), 46% were of normal weight (BMI 20–25 kg/m2) and 29% were overweight
(BMI425 kg/m2). Energy intake was lower than the calculated energy demand for all
groups. During the follow-up period, 24 of the 41 patients had an exacerbation. A
low BMI at inclusion and weight loss during the follow-up period were independent
risk factors for having an exacerbation (P ¼ 0.003 and 0.006, respectively).
We conclude that, in patients who are hospitalised because of COPD, underweight
and weight loss during the follow-up period are related to a higher risk of having new
exacerbations.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Chronic obstructive pulmonary disease (COPD) is
one of the leading causes of disability and mortality
in the world.1,2 Patients with COPD often have
exacerbations which lead to a more rapid decline in
Forced expiratory volume in 1 s (FEV1),
3 impaired
quality of life4 and higher mortality.5 Exacerbations
also lead to an increase in the need for medical
care and hospitalisation, thereby causing increases
in health-care costs.2
Loss of body weight, as a result of imbalance
between increased energy demand and/or reduced
dietary intake, is a common and serious problem
for patients with COPD.6–8 Moreover, weight loss is
an independent predictor of morbidity9,10 and
mortality.10–14 There is also evidence to suggest
that weight gain can reverse this increased mor-
tality risk.12 Loss of body weight in COPD is of
multifactorial origin. Eating difficulties,15,16 higher
metabolic rate and cost of ventilation,17 together
with oxidative stress causing systemic inflamma-
tion,18,19 are important factors. Even though
weight loss is of multifactorial origin, eating habits
and energy intake probably is of major importance.
Most studies of energy intake in COPD patients are
supplementation studies and few are available in
which the relationship between exacerbations,
habitual energy intake and different classes of
body mass index (BMI) are examined.
The aim of this investigation was to study the
possible connections between nutritional status
body mass index (BMI), dietary energy intake,
weight change and the risk of acute exacerbations,
in patients with COPD.Method
The study population was recruited from the
Swedish part of a prospective multicentre, re-
admission study of consecutive patients with
acute exacerbations of COPD, admitted to hos-
pital in the five Nordic countries.20 All the patients
had COPD according to the Global Initiative for
Chronic Obstructive Pulmonary Disease (GOLD)
criteria.21
Data were obtained before patients were dis-
charged and at a follow-up 1 year after inclusion.
During the first admission, height was measured to
the nearest 0.5 cm, while weight was measured on
a balance scale to the nearest 0.1 kg and BMI was
calculated as weight (kg)/length (m)2. Assessments
were made in the morning and within the first 48 h
of admission.A structured interview protocol was used and the
patients were asked about smoking habits and
history, social situation, education and disease
duration.
Spirometry was performed at discharge in most
patients. The spirometry was performed with a
Jaeger master scope spirometer (Jaeger, Ho¨chberg,
Germany). In the ten patients in whom spirometry
was not performed, the result from the most recent
previous spirometry was used. FEV1 was expressed
as a percentage of the predicted value using the
references values from the European Coal and Steel
Union.22
At the follow-up after 1 year, a telephone
interview was held with all patients. The patients
were then asked about their current weight, if they
had been given information om COPD and nutrition
and use of diet supplementation. At follow-up,
patients were also asked to complete a food diary
for 7 days.
Nutritional intake was assessed by a food diary.23
After the telephone interview, the food diary was
sent to the patients by mail, together with
instructions on how to fill it in. Instructions were
also given by phone at the interview and patients
were encouraged to call the interviewer if they had
any problems. Patients were asked to record
everything they had to eat and drink for 7
consecutive days. From the food diary results,
energy need and energy intake were calculated
using with the Dietist computer program (Kost och
Na¨ringsdata AB, Bromma, Sweden) using food data
from the Swedish National Food Administration.
The computer program uses the Harris–Benedict
equation and a basal metabolic rate (BMR) of 140 kJ
for ill yet mobile persons.
The patients were divided into three groups,
underweight (BMIo20), normal weight (BMI 20–25)
and overweight (BMI425). Weight change during
the 12-month period was calculated as the
reported weight at the follow-up minus the
measured weight at baseline.
Information on COPD exacerbations was col-
lected from patient records. An exacerbation was
defined as an emergency visit to and/or admission
to hospital because of COPD.
The Ethics Committee at the Medical Faculty at
Uppsala University has approved of the study.Statistics
Statistical analyses were performed using Stat View
5.0 (SAS Institute Inc, Cary, NC, USA). A chi-squared
test and one way analysis of variance were used
when comparing patients in the different BMI
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analyses were used to study the relationship
between changes in body mass and energy defi-
ciency after adjustment for age, gender and base-
line BMI. The Kaplan–Meier survival analysis and
Cox regression analysis were used to study relation-
ships between nutritional data and the time to the
next COPD exacerbation. In the Cox regressions
adjustments were made fore age, gender, FEV1 and
pack years. A P-value of o0.05 was considered
statistically significant.Result
Of the 87 patients with COPD that were included in
the study, 13 had died within 12 months. The
remaining 74 took part in a follow-up phone
interview. Of these 74 patients, 42 completed a
food diary for 1 week. At baseline, there were no
statistically significant differences between the
patients who filled in or did not fill in the food
diary in terms of gender, age, pack years, FEV1 or
BMI.Table 1 Characteristics of the study patients, by BMI ca
Underweight
BMIo20 kg/m2 ðn ¼ 10Þ
Women 5 (50%)
Age (years) 68713
Pack years 21714z
Weight (kg) 5075
BMI (kg/m2 ) 1772
Admissions last year 1.271.2z
FEV1(% of predicted) 28714
7
Weight loss during follow-up 4 (40%)
zPo0:05 compared with normal weight group.
7Po0:05 compared with overweight group.
Table 2 Energy demand, intake and energy deficiency p
Underweight BMIo20 kg/
m2 ðn ¼ 10Þ
N
2
Energy demand (kcal) 17377161 2
Energy intake (% of
needed)
91719
Energy intake (kcal) 15777347 1
Energy deficiency (kcal) 1597324
zPo0:01 compared with underweight group.
7Po0:001 compared with underweight group.In one of the 42 patients who completed the
diary, body mass had not been recorded at base-
line. The subsequent analyses therefore included
41 patients. In Table 1, the baseline characteristics
of this patient group divided into BMI categories are
presented. The underweight group had significantly
fewer pack years than the normal-weight patient
group and a significantly lower FEV1 than the
overweight group. Underweight patients also had
significantly more exacerbations during the year
before inclusion in the study.
During the follow-up period, 78% of the patients
in the underweight group had been given
advice about their diet compared with 50% and
17% in the normal and overweight patient groups,
respectively ðP ¼ 0:01Þ. The proportion of patients
using diet supplementation was 60% in the under-
weight group compared with 5% and 0% in the
normal and overweight groups, respectively
ðPo0:001Þ. Energy intake was lower than energy
demand in all groups (Table 2). The level of energy
deficiency was significantly lower in the under-
weight group compared with the other groups
ðPo0:01Þ.tegories (n (%) or mean7SD).
Normal weight BMI
20–25 kg/m2 ðn ¼ 19Þ
Overweight BMI425 kg/
m2 ðn ¼ 12Þ
13 (68%) 9 (75%)
6879 6679
34713 29712
6276 83718
2272 3076
0.370.6 0.270.4
38717 46719
6 (32%) 6 (50%)
atients divided into BMI categories (mean7SD).
ormal weight BMI
0–25 kg/m2 ðn ¼ 19Þ
Overweight BMIo25 kg/
m2 ðn ¼ 12Þ
1347244 26267569
73713 56720
5667357 14067261
5677307z 122076627
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are shown in Table 1 and Fig. 1. There was a small
decrease in body mass in the overweight group and
a small increase in the under- and normal-weight
patient groups. Eighteen patients had decreased
body mass (range 0.5–12 kg). There was no sig-
nificant difference in baseline BMI between pa-
tients that had a weight loss and patients with
unchanged or increased weight (23.075.7 vs.
24.076.3 kg/m2, P ¼ 0:63). The association be-
tween energy deficiency and weight change is
presented in Fig. 2. No significant relationship
between energy deficiency and weight change was
found in the bivariate analysis (Fig. 2) or after
adjusting for age, gender and BMI at baseline
(r ¼ 0:24, P ¼ 0:30).
During the follow-up period, 24 of the 41 patients
had an exacerbation. The time until an exacerba--10
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Figure 1 Change in weight during 12 months in COPD
patients divided into BMI categories. The box plots show
the values of the median, the 25th and 75th percentiles
(box) and the 10th and 90th percentiles.
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Figure 2 Relationship between energy deficiency and
weight change.tion in the three different BMI groups is shown in
Fig. 3. The patients in the overweight group were
less likely to have an exacerbation. Compared with
the other two groups, this difference was of
borderline significance ðP ¼ 0:07Þ.
The group of patients that had a weight reduc-
tion during the follow-up had an increased like-
lihood of having an exacerbation compared with
patients whose weight was either unchanged or
increased (Po0:01) (Fig. 4).
In a multivariate analysis using the Cox regres-
sion model, a low BMI at baseline and weight
reduction during the follow-up period were found
to be independent risk factors for acute exa-
cerbations, whereas no significant associations were
found for FEV1, gender, age or pack years (Table 3).
No significant correlation was found between energy
deficiency and the risk of having an exacerbation.0
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Figure 3 Kaplan–Meier cumulative survival plot for days
until next COPD exacerbation in COPD patients divided
into BMI categories.
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Figure 4 Kaplan–Meier cumulative survival plot for days
until next COPD exacerbation in COPD patients with
reduced or unchanged/increased weight during the
follow-up period.
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Table 3 Relationship between body mass index
(BMI), weight change and covariates and the time
to the next COPD exacerbation analysed with the
Cox-regression model.
Risk ratio 95% confidence
intervaly
BMI at baseline 0.78 0.65–0.93
Weight change 0.76 0.63–0.93
FEV1 at baseline
(% of pred)y
0.90 0.60–1.34
Age (years)y 0.66 0.31–2.16
Male gender 0.72 0.22–2.38
Pack yearsy 1.34 0.82–2.16
Adjusted for all the variables in the table.
yPer 10 units.
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The main finding in this prospective study of
patients hospitalised with COPD is that under-
weight at baseline and weight loss during the 12-
month observation period were independant risk
factors of exacerbations. Our study also indicated
that insufficient energy intake is common among
patients with COPD, but we found no relationship
between deficiency in energy intake and the risk of
exacerbations.
The increased risk of exacerbations in patients
with underweight and weight loss found in our
study is consistent with other reports, that have
found an increased need of medical care and a
higher mortality in underweight COPD patients.9–13
In one study, Pouw and co-workers reported that
patients, who lost weight during an exacerbation-
related hospitalisation, had a higher risk of early
non-elective re-admission.10 In our study, we found
that patients with a BMI ofo20 had more exacer-
bations the year before inclusion. This patient
group also had the lowest number of pack years,
but, despite this, they also had also the lowest
mean FEV1. This may reflect the findings of
Harik–Khan, that low-weight smokers are at a
higher risk of developing COPD than normal and
overweight smokers.24 It is well known that having
a low FEV1, is a risk factor for exacerbations.
4,25
The association between underweight, weight
change and exacerbation frequency was therefore
investigated with adjustments for FEV1 in the Cox-
regression model. In the present study the risk of
exacerbations increased with decreasing FEV1 but
the association was not statistically significant,
probably due to the limited number of patients in
the study.Our food diary results suggest that an insufficient
dietary intake is very common in COPD patients. In
a recent study, Tang et al.,26 found a significant
negative energy balance due to insufficient intake,
in seven out of ten patients. In one study, patients
hospitalised for an exacerbation have been found
to be in negative nitrogen balance, but some small
gains were observed with increased energy in-
take.27 In hospitalised patients in Iceland, the
energy intake was 140% of the calculated needs,
and this level was found to be sufficient to avoid
protein losses, but a higher intake is needed to
rehabilitate undernourished patients.28 In our study
we found no significant association between energy
deficiency and weight loss and energy deficiency
was lowest in the group of patients with a BMI
ofo20 kg/m2. This is probably explained by the
more intensive information and use of food
supplementation found in this group of patients.
Another reason for the somewhat paradoxical
relationship between body mass and energy defi-
ciency may be that over weight patients tend to
under-report their food intake. Energy expenditure
was not measured, and calculation of energy
demand were made using the Harris–Benedict
equation and with a basal metabolic rate (BMR) of
140 kcal for ill yet mobile persons. In COPD patients
the variation in total daily energy expenditure
reflect differences in expenditures for activities
but not for resting energy expenses (REE),29,30 this
may have affected the relation between energy
intake deficiency and weight change, as the level of
activity varies between patients.
This study has several limitations. The food diary
was completed 1 year after inclusion in the study
and covers only 1 week. The reported energy intake
may therefore not reflect the whole study period in
some patients. Weight loss was calculated from
measured weight at inclusion and reported weight
at the follow-up, which may also lead to some
misclassification. Despite the fact that this is a
prospective study, the causal relationship between
weight loss and exacerbations remains unclear to
some extent. Frequent exacerbations causes
weight loss as a result of impaired energy balance
due to reduced dietary intake and an increase in
resting energy expenditure.31 Systemic inflamma-
tion is another possible cause of weight loss during
exacerbations 32 and is more pronounced during
exacerbations.14 It is therefore still difficult to
know whether weight loss and low weight is a cause
or a consequence of exacerbations.
Despite the limitations, this study highlights the
prognostic implications of malnutrition in COPD.
Even if weight loss is of multifactorial origin,
energy intake is probably of importance. One cause
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many malnourished COPD patients and it has been
suggested that this can be explained by, a cytokine-
leptin link leading to increased levels of leptin.
These increased leptin levels leads to reduced food
intake and higher energy demand and therefore
poor response to nutritional support.27 Apart from
systemic inflammation, elevated leptin levels are
also related to exacerbations and presumably to
corticoid treatment.33 The most natural way of
treating malnutrition in COPD is probably by
nutritional support. At present, there is limited
evidence to suggest that nutritional support has any
impact on malnutrition in COPD patients.34 Two
recent reports did, however, show that nutritional
supplementation therapy implemented in a pul-
monary rehabilitation programme was effective in
depleted patients with COPD.35,36
We conclude that underweight and weight loss
during the follow-up period was related to a higher
risk of exacerbations in patients with COPD. This
study underlines the importance of examining
nutritional status and monitoring weight changes
in patients with severe COPD.Acknowledgements
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